Imaging biomarkers and their role in dementia clinical trials.
about
Using structural and diffusion magnetic resonance imaging to differentiate the dementias.Predicting treatment outcome in stimulant dependenceInterpreting biomarker data in therapeutic trials.Multisite neuroimaging trials.Functional response in ventral temporal cortex differentiates mild cognitive impairment from normal aging.Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's diseasePreclinical AD Workgroup staging: pathological correlates and potential challenges.Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story.MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials.Imaging biomarkers: from research to patient care--a shift in view.Semantic memory activation in amnestic mild cognitive impairment.Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment.Thioflavin derivatives as markers for amyloid-beta fibrils: insights into structural features important for high-affinity binding.Neurocognitive disorders: cluster 1 of the proposed meta-structure for DSM-V and ICD-11.
P2860
Q30836806-805D9C5C-3766-49BB-87E6-66A981A7C454Q33383362-DB1900E4-0DD8-40C4-A598-AB0368784BC0Q33419934-71A3347A-3DB3-48FA-A9EF-2ADEBF5F62FCQ33464142-ACBE351D-A18E-4C38-B2A7-0B8847FBD9F2Q34415697-313BA6CB-99A6-4D83-8CF0-CACA961B1378Q34533985-0BC90CC2-159A-4B88-B987-DFCC020B0DF2Q35633470-CF866F5F-F5E6-437C-912A-A4B2BD190B26Q35687048-A4F4B730-9B65-4087-8B2D-02A5C10EB82DQ36475090-7EB5D14F-2D3F-40D0-B786-8C2066DC15E5Q36785972-21FC8D13-6D62-47C2-85B2-639E966E8001Q36933272-01306F85-FB44-474B-A245-428F5B563884Q37270625-43CA6DFF-CD7B-4C1E-A005-A99A3AE6FF39Q37755075-01B78927-1733-4705-BA2D-C7B0B5E29E08Q46958372-E3517CFF-D80D-4137-B32F-6F2E4BA92AD7Q48445053-75089990-BB1B-4940-A856-AE68BE3653F2
P2860
Imaging biomarkers and their role in dementia clinical trials.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Imaging biomarkers and their role in dementia clinical trials.
@ast
Imaging biomarkers and their role in dementia clinical trials.
@en
type
label
Imaging biomarkers and their role in dementia clinical trials.
@ast
Imaging biomarkers and their role in dementia clinical trials.
@en
prefLabel
Imaging biomarkers and their role in dementia clinical trials.
@ast
Imaging biomarkers and their role in dementia clinical trials.
@en
P2860
P1476
Imaging biomarkers and their role in dementia clinical trials.
@en
P2093
Sandra Black
P2860
P304
P356
10.1017/S031716710000562X
P478
34 Suppl 1
P577
2007-03-01T00:00:00Z